Susceptibility markers include intrinsic genetic or other characteristics, such as single-nucleotide polymorphisms, or preexisting diseases that result in an increase in internal dose, biologically effective dose, or target tissue response.
Susceptibility markers include intrinsic genetic or other characteristics, such as single-nucleotide polymorphisms, or preexisting diseases that result in an increase in internal dose, biologically effective dose, or target tissue response.